Capital Raising PresentationASX:NYR21 September 2026Authorised by Mr. John Moore, Non-Executive Chair, on behalf of the BoardNot for release to US wire services or distribution in the United StatesBuilding the Future of TRPC-based TherapiesImportant Notice and Disclaimer This presentation has been...